Clinical and Prognostic Implications of WT1 Mutations in De Novo and Relapsed Acute Myeloid Leukemia

被引：0

作者：

Atluri, Himachandana ^{[1
]}

DiGennaro, Jeremy ^{[2
]}

Patel, Keyur P. ^{[3
]}

Routbort, Mark ^{[4
]}

Oran, Betul ^{[5
]}

Issa, Ghayas C. ^{[6
]}

Short, Nicholas J. ^{[7
]}

Daver, Naval ^{[7
]}

Kadia, Tapan M. ^{[7
]}

Ravandi, Farhad ^{[7
]}

Popat, Uday R. ^{[5
]}

Champlin, Richard E. ^{[5
]}

Shpall, Elizabeth J. ^{[5
]}

Pierce, Sherry ^{[7
]}

Kanagal-Shamanna, Rashmi ^{[3
]}

Ok, Chi Young ^{[4
]}

Tang, Guilin ^{[4
]}

Wang, Sa A. ^{[3
]}

Luthra, Raja ^{[4
]}

Lasry, Audrey ^{[8
]}

Nadorp, Bettina ^{[9
]}

Chroni, Antonia ^{[8
]}

Eisfeld, Ann-Kathrin ^{[10
]}

Aifantis, Iannis ^{[8
]}

Al Ali, Najla H. ^{[11
]}

Sallman, David A. ^{[11
]}

Lancet, Jeffrey ^{[11
]}

Chan, Onyee ^{[11
]}

Padron, Eric ^{[11
]}

Xie, Zhuoer ^{[11
]}

Medeiros, L. Jeffrey ^{[4
]}

DiNardo, Courtney D. ^{[7
]}

Komrokji, Rami S. ^{[11
]}

Loghavi, Sanam ^{[4
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX USA

[2] Univ S Florida, Dept Internal Med, Tampa, FL USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX USA

[4] Univ Texas MD Anderson Canc Ctr, Hematopathol, Houston, TX USA

[5] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX USA

[6] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[7] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA

[8] NYU, Grossman Sch Med, Dept Pathol, New York, NY USA

[9] NYU, Div Precis Med, Dept Med, Grossman Sch Med, New York, NY USA

[10] Ohio State Univ, Clara D Bloomfield Ctr Leukemia Outcomes Res, Columbus, OH USA

[11] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-188319

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：6

共 50 条

[31] Prognostic significance of diagnosed WT1 level in acute myeloid leukemia: a meta-analysis
Yang Yi-ning
Wang Xiao-rui
Zhao Chu-xian
Wang Chun
Qin You-wen
ANNALS OF HEMATOLOGY, 2015, 94 (06) : 929 - 938
[32] WT1 IN CHRONIC MYELOID LEUKEMIA
Coluzzi, S.
Introcaso, T.
Iallorenzi, P.
Villani, O.
Bianchino, G.
Perutelli, F.
Guerrin, F.
Pascale, S. P.
Attolico, I.
Vertone, D.
Filardi, N.
Matturro, A.
Amendola, A.
Pietrantuono, G.
Galimberti, S.
Pizzuti, M.
HAEMATOLOGICA, 2017, 102 : 91 - 92
[33] Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1
Andrew B. Das
Purvi M. Kakadia
Damian Wojcik
Lucy Pemberton
Peter J. Browett
Stefan K. Bohlander
Margreet C. M. Vissers
Blood Cancer Journal, 9
[34] WT1 Mutation Is an Independent Poor Prognostic Factor in Intermediate Risk Acute Myeloid Leukemia (AML): A Case of Relapsed AML with Leukostasis
Hakim, N.
Arora, R.
Stocks-Candelaria, J. J.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1138 - 1138
[35] Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1
Das, Andrew B.
Kakadia, Purvi M.
Wojcik, Damian
Pemberton, Lucy
Browett, Peter J.
Bohlander, Stefan K.
Vissers, Margreet C. M.
BLOOD CANCER JOURNAL, 2019, 9 (10)
[36] Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia.
Suzuki, T
Kiyoi, H
Ozeki, K
Tomita, A
Suzuki, R
Kodera, Y
Miyawaki, S
Asou, N
Kuriyama, K
Yagasaki, F
Shimazaki, C
Akiyama, H
Nishimura, M
Motoji, T
Shinagawa, K
Takeshita, A
Ueda, R
Naoe, T
BLOOD, 2005, 106 (11) : 666A - 666A
[37] Impact of PTPN11 Mutations in De Novo, Secondary and Relapsed/Refractory Acute Myeloid Leukemia
Coltoff, Alexander
Smith, Deidra
Davis, James A.
Gaffney, Kelly J.
Baratam, Praneeth
Green, Kimberly Michelle
BLOOD, 2023, 142
[38] Activity of bortezomib in adult de novo and relapsed acute myeloid leukemia
Gil, Lidia
Styczynski, Jan
Dytfeld, Dominik
Debski, Robert
Kazmierczak, Maciej
Kolodziej, Beata
Rafinska, Beata
Kubicka, Malgorzata
Nowicki, Adam
Komarnicki, Mieczyslaw
Wysocki, Mariusz
ANTICANCER RESEARCH, 2007, 27 (6B) : 4021 - 4025
[39] PROGNOSTIC IMPORTANCE OF MUTATIONS IN THE RAS PROTOONCOGENES IN DE-NOVO ACUTE MYELOID-LEUKEMIA
NEUBAUER, A
DODGE, RK
GEORGE, SL
DAVEY, FR
SILVER, RT
SCHIFFER, CA
MAYOR, RJ
BALL, ED
WURSTERHILL, D
BLOOMFIELD, CD
LIU, ET
BLOOD, 1994, 83 (06) : 1603 - 1611
[40] Analysis of WT1 mutations, expression levels and single nucleotide polymorphism rs16754 in de novo non-M3 acute myeloid leukemia
Luo, Sheng
Yu, Kang
Yan, Qing-xian
Shen, Zhi-jian
Wu, Jian-bo
Chen, Hai-min
Gao, Shen-meng
LEUKEMIA & LYMPHOMA, 2014, 55 (02) : 349 - 357

← 1 2 3 4 5 →